Literature DB >> 19836632

Is there a relationship between high C-reactive protein (CRP) levels and dementia?

A Mancinella1, M Mancinella, G Carpinteri, A Bellomo, C Fossati, V Gianturco, A Iori, E Ettorre, G Troisi, V Marigliano.   

Abstract

Inflammation is believed to play a pivotal role in dementia, but its role is still unclear. The aim of our study was to analyze the interplay among markers of inflammation, such as fibrinogen and high CRP levels, and dementia. First, we performed a cross-sectional study comparing markers of inflammation between 99 patients affected by dementia (mean age: 83.0+/-0.6 years) and 99 controls (mean age: 83.9+/-0.7 years). Then, we analyzed the relationship between inflammation and dementia in the same population composed by 34 Alzheimer's disease (AD) patients (mean age: 83.4+/-0.8 years), 64 vascular dementia (VaD) patients (mean age: 82.7+0.8 years) and 99 controls. Patients affected by dementia had higher CRP levels than controls (2.6+/-+/-0.2 vs. 0.7 + 0.1 p < 0.001, respectively). AD patients had higher CRP levels than VaD patients (4.2 + 0.6 vs. 1.7+/-0.2, p < 0.001, respectively). Stepwise multiple logistic regression analysis showed that dementia (odds ratio=OR=4.965, 95% confidence interval=Cl=1.402-13.23, p=0.004), fibrinogen (OR=1.011, Cl=1.007-1.015, p<0.001), and age (OR=1.158, Cl=1.063-1.261, p<0.001) are independently correlated with high levels of CRP. The study suggests that inflammation may have a pathogenetic role in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836632     DOI: 10.1016/j.archger.2009.09.028

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  20 in total

1.  Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss.

Authors:  Shruti Gupta; Sharon G Curhan; Gary C Curhan
Journal:  Ear Hear       Date:  2019 Jul/Aug       Impact factor: 3.570

2.  Biomarkers of basic activities of daily living in Alzheimer's disease.

Authors:  James R Hall; Leigh A Johnson; Robert C Barber; Hoa T Vo; A Scott Winter; Sid E O'Bryant
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Development and validation of risk index for cognitive decline using blood-derived markers.

Authors:  Jasmine Nettiksimmons; Hilsa Ayonayon; Tamara Harris; Caroline Phillips; Caterina Rosano; Suzanne Satterfield; Kristine Yaffe
Journal:  Neurology       Date:  2015-01-21       Impact factor: 9.910

4.  Allostatic load and reduced cortical thickness in schizophrenia.

Authors:  Joshua Chiappelli; Peter Kochunov; Anya Savransky; Feven Fisseha; Krista Wisner; Xiaoming Du; Laura M Rowland; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2016-11-24       Impact factor: 4.905

Review 5.  Blood-based biomarkers of Alzheimer's disease: challenging but feasible.

Authors:  Madhav Thambisetty; Simon Lovestone
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

6.  Declines in inflammation predict greater white matter microstructure in older adults.

Authors:  Brianne Magouirk Bettcher; Kristine Yaffe; Robert M Boudreau; John Neuhaus; Howard Aizenstein; Jingzhong Ding; Stephen B Kritchevsky; Lenore J Launer; Yongmei Liu; Suzanne Satterfield; Caterina Rosano
Journal:  Neurobiol Aging       Date:  2014-11-13       Impact factor: 4.673

7.  Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.

Authors:  Christian Lunetta; Andrea Lizio; Eleonora Maestri; Valeria Ada Sansone; Gabriele Mora; Robert G Miller; Stanley H Appel; Adriano Chiò
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

8.  Neuroinflammatory phenotype in early Alzheimer's disease.

Authors:  Tiffany L Sudduth; Frederick A Schmitt; Peter T Nelson; Donna M Wilcock
Journal:  Neurobiol Aging       Date:  2012-10-09       Impact factor: 4.673

9.  Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.

Authors:  Ewa Bulzacka; Laurent Boyer; Franck Schürhoff; Ophélia Godin; Fabrice Berna; Lore Brunel; Méja Andrianarisoa; Bruno Aouizerate; Delphine Capdevielle; Isabelle Chéreau-Boudet; Gabrielle Chesnoy-Servanin; Jean-Marie Danion; Caroline Dubertret; Julien Dubreucq; Catherine Faget; Franck Gabayet; Tifenn Le Gloahec; Pierre-Michel Llorca; Jasmina Mallet; David Misdrahi; Romain Rey; Raphaëlle Richieri; Christine Passerieux; Paul Roux; Hanan Yazbek; Marion Leboyer; Guillaume Fond
Journal:  Schizophr Bull       Date:  2016-05-03       Impact factor: 9.306

10.  The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease.

Authors:  Eşref Akıl; Aslıhan Bulut; İbrahim Kaplan; Hasan Hüseyin Özdemir; Demet Arslan; Mehmet Ufuk Aluçlu
Journal:  Neurol Sci       Date:  2014-10-07       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.